BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Business

  Akzo Nobel N.V. Announces Q3 2006: Delivering On Profitable Growth, Continued Rise In Revenues And Operational Earnings

  October 18, 2006

   · 

  1 min read
• BioMidwest

  Neogen Corporation Again Named One Of Forbes’ 200 Best Small Companies

  October 18, 2006

   · 

  2 min read
• Business

  Molecular Innovations, Inc. Breaks Ground On New R&D, Lab Facility

  October 18, 2006

   · 

  2 min read
• Business

  Medicines For Malaria Venture, Genzyme Corporation And The Broad Institute Expand Collaboration To Discover New Drugs For Malaria

  October 18, 2006

   · 

  7 min read
• Drug Development

  Akzo Nobel N.V. Says Asenapine May Be Delayed, Shares Fall

  October 18, 2006

   · 

  1 min read
• Policy

  Ambry Genetics Agrees To Pay Roche Diagnostics Royalties Due For Licensing Of PCR Technology

  October 18, 2006

   · 

  1 min read
• BioMidwest

  Coronado Industries Edges Closer toward Marketing Their PNT Glaucoma Treatment In China

  October 18, 2006

   · 

  1 min read
• AlphaRx International Holdings Limited Enters Oncology Market

  October 18, 2006

   · 

  1 min read
• Business

  Averion International Corp. Announces Appointment Of Donald Schelling As Program Director, Dermatology

  October 18, 2006

   · 

  1 min read
• Business

  Bayer HealthCare AG And Regeneron Pharmaceuticals, Inc. To Collaborate On VEGF Trap For The Treatment Of Eye Diseases; Regeneron Retains U.S. Commercialization Rights, Receives $75 Million Upfront, And Eligible For Up To $245 Million Of Milestone Payments

  October 18, 2006

   · 

  7 min read